| Date Filed | Type | Description |
| 06/30/2023 |
SC 13D/A
| KIRK RANDAL J reports a 4.9% stake in AQUABOUNTY TECHNOLOGIES, INC. |
| 06/07/2023 |
SC 13D/A
| KIRK RANDAL J reports a 6.3% stake in AQUABOUNTY TECHNOLOGIES, INC. |
| 01/31/2023 |
SC 13D/A
| KIRK RANDAL J reports a 38.3% stake in PRECIGEN, INC. |
| 10/07/2022 |
SC 13D/A
| KIRK RANDAL J reports a 40.7% stake in PRECIGEN, INC. |
| 11/24/2021 |
SC 13D/A
| KIRK RANDAL J reports a 7.5% stake in AQUABOUNTY TECHNOLOGIES, INC. |
| 12/21/2020 |
SC 13D/A
| KIRK RANDAL J reports a 43.6% stake in PRECIGEN, INC. |
| 12/21/2020 |
SC 13D/A
| KIRK RANDAL J reports a 33.1% stake in AQUABOUNTY TECHNOLOGIES, INC. |
| 10/08/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/13/2020 |
SC 13D/A
| KIRK RANDAL J reports a 48.7% stake in PRECIGEN, INC. |
| 08/13/2020 |
SC 13D/A
| KIRK RANDAL J reports a 42.3% stake in AQUABOUNTY TECHNOLOGIES, INC. |
| 03/02/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/18/2020 |
SC 13D/A
| KIRK RANDAL J reports a 44.6% stake in AQUABOUNTY TECHNOLOGIES, INC. |
| 02/04/2020 |
SC 13D/A
| KIRK RANDAL J reports a 48.2% stake in PRECIGEN, INC. |
| 01/06/2020 |
SC 13D/A
| KIRK RANDAL J has filed a Schedule 13D for INTREXON CORPORATION |
| 11/05/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/31/2019 |
SC 13D/A
| KIRK RANDAL J reports a 42% stake in AQUABOUNTY TECHNOLOGIES, INC. |
| 09/17/2019 |
SC 13D/A
| KIRK RANDAL J has filed a Schedule 13D for FIBROCELL SCIENCE, INC. |
| 07/03/2019 |
SC 13D/A
| KIRK RANDAL J reports a 7.2% stake in HALOZYME THERAPEUTICS, INC. |
| 06/10/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/07/2019 |
SC 13D/A
| KIRK RANDAL J reports a 8.3% stake in HALOZYME THERAPEUTICS, INC. |
| 05/15/2019 |
SC 13D/A
| KIRK RANDAL J reports a 43.7% stake in INTREXON CORPORATION |
| 04/03/2019 |
SC 13D/A
| KIRK RANDAL J reports a 1.5% stake in SYNTHETIC BIOLOGICS, INC. |
| 01/15/2019 |
SC 13D/A
| KIRK RANDAL J reports a 2.7% stake in HISTOGENICS CORPORATION |
| 12/12/2018 |
SC 13D/A
| KIRK RANDAL J reports a 4.9% stake in ZIOPHARM ONCOLOGY, INC. |
| 10/29/2018 |
SC 13D/A
| KIRK RANDAL J reports a 60.1% stake in AQUABOUNTY TECHNOLOGIES, INC. |
| 10/15/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/14/2018 |
SC 13D/A
| KIRK RANDAL J reports a 4.8% stake in PRECIPIO, INC. |
| 08/28/2018 |
SC 13D/A
| KIRK RANDAL J reports a 9.8% stake in HALOZYME THERAPEUTICS, INC. |
| 08/16/2018 |
SC 13D/A
| KIRK RANDAL J reports a 11% stake in HALOZYME THERAPEUTICS, INC. |
| 07/06/2018 |
SC 13D/A
| KIRK RANDAL J reports a 48.8% stake in INTREXON CORPORATION |
| 01/22/2018 |
SC 13D/A
| KIRK RANDAL J reports a 45.7% stake in INTREXON CORPORATION |
| 01/19/2018 |
SC 13D/A
| KIRK RANDAL J reports a 64.3% stake in AQUABOUNTY TECHNOLOGIES, INC. |
| 01/02/2018 |
SC 13D/A
| KIRK RANDAL J reports a 47.4% stake in INTREXON CORPORATION |
| 12/13/2017 |
SC 13D/A
| KIRK RANDAL J reports a 43.7% stake in FIBROCELL SCIENCE, INC. |
|